Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Surgeon Survey Finds Variation In Training With da Vinci System

This article was originally published in The Gray Sheet

Executive Summary

An FDA survey of 11 surgeons with experience using Intuitive Surgical’s da Vinci robotic surgical system shows respondents reported having difficulty learning how to use the device’s complex user interface.

You may also be interested in...



Expert Calls On Professional Societies To Step Up On Robotic Surgery

While manufacturers can provide basic training on robotically-assisted surgical devices (RASD), academic institutions and professional societies need to work together to propose curricula and credentialing standards to FDA, says minimally invasive surgeon Steven Schwaitzberg.

Regulate Robotic Surgery Devices By Function, Not Indication, Stakeholders Tell FDA

Industry and physicians speaking at a two-day FDA meeting on robotically-assisted surgical devices emphasized the need to regulate the technology as any other surgical tool, with Intuitive Surgical proposing a new regulatory paradigm to accomplish that. Meanwhile, the company and surgeons differ on who should be leading physician training on the robotic systems.

FDA Raises Design, Training Questions With Surgical Robots

The agency is set to hold a workshop on Robotically-Assisted Surgical Devices later this month. In advance, FDA issued a discussion document exploring questions and concerns over how to regulate these devices in the future.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT032590

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel